Sidney C. Smith Jr, MD |
University of North Carolina, Chapel Hill |
None |
None |
Honoraria: *Bayer, *BMS, *Sanofi-Aventis |
None |
*Sanofi-Aventis, *GlaxoSmithKline, *Eli Lilly, *Pfizer, *Merck |
*Astra-Zeneca (Data Safety Monitoring Board) |
Jerilyn Allen, RN, ScD |
Johns Hopkins University, School of Nursing |
None |
None |
None |
None |
*Board of Directors, Preventive Cardiovascular Nurses Association; Board of Directors, Southeast Lipid Association |
None |
Steven N. Blair, PED |
Cooper Institute |
**HealthTech, **Jenny Craig |
None |
Donates all honoraria to The Cooper Institute |
None |
**Miavita, **Life Fitness, **Jenny Craig |
All items listed pertain to the Cooper Institute. Does not personally receive money from any of these. |
Robert O. Bonow, MD |
Northwestern University, School of Medicine |
None |
None |
*Bristol-Myers Squibb Medical Imaging |
None |
*Bristol-Myers Squibb Medical Imaging, King Pharmaceuticals |
These are no relationship to current writing committee; they are included for completeness. |
Lawrence M. Brass, MD |
Yale University |
Bristol-Myers Squibb, Sanofi/Synthelabo* |
None |
Bristol-Myers Squibb, Sanofi/Synthelabo, Solvay Pharmaceuticals, Wyeth |
None |
AstraZeneca, Bristol-Myers Squibb, Johnson&Johnson, Merck, ONO Pharmaceuticals, Sanofi/Synthelabo, Solvay Pharmaceuticals, Wyeth |
None |
Gregg C. Fonarow, MD |
University of California, Los Angeles |
**GlaxoSmithKline, **Medtronic |
None |
**GlaxoSmithKline, **Merck–Schering Plough, **Bristol-Myers Squibb–Sanofi, *AstraZeneca, *Wyeth |
None |
**GlaxoSmithKline, **Pfizer, **Merck–Schering Plough, **Bristol-Myers Squibb–Sanofi, *AstraZeneca, *Wyeth |
None |
Scott M. Grundy, MD, PhD |
University of Texas Southwestern |
**Abbott, **GlaxoSmithKline |
**Donald W. Reynolds Foundation, **VA Hospital |
*Merck, Schering-Plough, *GlaxoSmithKline, *Pfizer, *Kos, *Bristol-Myers Squibb, *Lilly |
*None |
*Pfizer, *Sanofi-Aventis, *Abbott, *AstraZeneca, *GlaxoSmithKline |
None |
Loren Hiratzka, MD |
TriHealth, Inc |
None |
None |
None |
None |
None |
None |
Daniel Jones, MD |
University of Mississippi Medical Center |
None |
None |
None |
None |
None |
None |
Harlan M. Krumholz, MD |
Yale University |
**CV Therapeutics |
None |
None |
None |
*CV Therapeutics, **VHA Inc (Consultant), **United Healthcare (Advisory), **CFMC (Clin Coordinator), **MMS (Editorial Board) |
|
Lori Mosca, MD, PhD, MPH |
New York Presbyterian |
**NIH |
*Pfizer |
*Kos, *Abbott, *AstraZeneca, *Pfizer, *Sanofi-Aventis |
None |
*Kos, *Pfizer, *Sanofi-Aventis, *Schering-Plough |
None |
Thomas Pearson, MD, MPH, PhD |
University of Rochester |
**World Heart Federation, *Schering-Plough,
*Pfizer, *Merck, *Sanofi-Aventis |
None |
*Kos, *Abbott, *AstraZeneca, *Pfizer, *Schering-Plough, *Bayer, *Merck |
None |
**Meditech, *Johnson&Johnson, Merck, *Bayer, *Sanofi-Aventis |
None |
Marc A. Pfeffer, MD, PhD |
Brigham & Women's Hospital |
Amgen, Atherogenics, Novartis, Bristol-Myers, Squibb, Sanofi-Synthelabo** |
None |
None |
The Brigham & Women's Hospital has been awarded patents related to the use of inhibitors of the renin-angiotensin system in selected survivors. He is co-inventor. However, the licensing agreement is not linked to sales.** |
**AstraZeneca, **Genzyme, **Guidant, **Mitsubishi, *Abbott, *Amgen, *Bristol-Myers Squibb, *CSL, *Novartis, *Sankyo, *Pfizer |
None |
Kathryn A. Taubert, PhD |
American Heart Association |
None |
None |
None |
None |
None |
None |